BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28459464)

  • 1. Bone morphogenetic protein signaling mediated by ALK-2 and DLX2 regulates apoptosis in glioma-initiating cells.
    Raja E; Komuro A; Tanabe R; Sakai S; Ino Y; Saito N; Todo T; Morikawa M; Aburatani H; Koinuma D; Iwata C; Miyazono K
    Oncogene; 2017 Aug; 36(35):4963-4974. PubMed ID: 28459464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine kinase Eph receptor A6 sensitizes glioma-initiating cells towards bone morphogenetic protein-induced apoptosis.
    Raja E; Morikawa M; Nishida J; Tanabe R; Takahashi K; Seeherman HJ; Saito N; Todo T; Miyazono K
    Cancer Sci; 2019 Nov; 110(11):3486-3496. PubMed ID: 31483918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paired related homeobox 1 transactivates dopamine D2 receptor to maintain propagation and tumorigenicity of glioma-initiating cells.
    Li Y; Wang W; Wang F; Wu Q; Li W; Zhong X; Tian K; Zeng T; Gao L; Liu Y; Li S; Jiang X; Du G; Zhou Y
    J Mol Cell Biol; 2017 Aug; 9(4):302-314. PubMed ID: 28486630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Midkine signaling maintains the self-renewal and tumorigenic capacity of glioma initiating cells.
    López-Valero I; Dávila D; González-Martínez J; Salvador-Tormo N; Lorente M; Saiz-Ladera C; Torres S; Gabicagogeascoa E; Hernández-Tiedra S; García-Taboada E; Mendiburu-Eliçabe M; Rodríguez-Fornés F; Sánchez-Domínguez R; Segovia JC; Sánchez-Gómez P; Matheu A; Sepúlveda JM; Velasco G
    Theranostics; 2020; 10(11):5120-5136. PubMed ID: 32308772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone morphogenetic proteins.
    Chen D; Zhao M; Mundy GR
    Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol promotes proteasome-dependent degradation of Nanog via p53 activation and induces differentiation of glioma stem cells.
    Sato A; Okada M; Shibuya K; Watanabe E; Seino S; Suzuki K; Narita Y; Shibui S; Kayama T; Kitanaka C
    Stem Cell Res; 2013 Jul; 11(1):601-10. PubMed ID: 23651583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type-3 metabotropic glutamate receptors negatively modulate bone morphogenetic protein receptor signaling and support the tumourigenic potential of glioma-initiating cells.
    Ciceroni C; Arcella A; Mosillo P; Battaglia G; Mastrantoni E; Oliva MA; Carpinelli G; Santoro F; Sale P; Ricci-Vitiani L; De Maria R; Pallini R; Giangaspero F; Nicoletti F; Melchiorri D
    Neuropharmacology; 2008 Sep; 55(4):568-76. PubMed ID: 18621067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of RAF/MEK or PI3K synergizes cytotoxicity of receptor tyrosine kinase inhibitors in glioma tumor-initiating cells.
    Shingu T; Holmes L; Henry V; Wang Q; Latha K; Gururaj AE; Gibson LA; Doucette T; Lang FF; Rao G; Yuan L; Sulman EP; Farrell NP; Priebe W; Hess KR; Wang YA; Hu J; Bögler O
    J Transl Med; 2016 Feb; 14():46. PubMed ID: 26861698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tanshinone IIA inhibits the growth, attenuates the stemness and induces the apoptosis of human glioma stem cells.
    Yang L; Guo H; Dong L; Wang L; Liu C; Wang X
    Oncol Rep; 2014 Sep; 32(3):1303-11. PubMed ID: 24970314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distal-less homeobox 2 promotes the osteogenic differentiation potential of stem cells from apical papilla.
    Qu B; Liu O; Fang X; Zhang H; Wang Y; Quan H; Zhang J; Zhou J; Zuo J; Tang J; Tang Z
    Cell Tissue Res; 2014 Jul; 357(1):133-43. PubMed ID: 24756434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
    Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
    Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells.
    Piccirillo SG; Reynolds BA; Zanetti N; Lamorte G; Binda E; Broggi G; Brem H; Olivi A; Dimeco F; Vescovi AL
    Nature; 2006 Dec; 444(7120):761-5. PubMed ID: 17151667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone morphogenetic protein 4 inhibits cell proliferation and induces apoptosis in glioma stem cells.
    Zhou Z; Sun L; Wang Y; Wu Z; Geng J; Miu W; Pu Y; You Y; Yang Z; Liu N
    Cancer Biother Radiopharm; 2011 Feb; 26(1):77-83. PubMed ID: 21355779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Snail depletes the tumorigenic potential of glioblastoma.
    Savary K; Caglayan D; Caja L; Tzavlaki K; Bin Nayeem S; Bergström T; Jiang Y; Uhrbom L; Forsberg-Nilsson K; Westermark B; Heldin CH; Ferletta M; Moustakas A
    Oncogene; 2013 Nov; 32(47):5409-20. PubMed ID: 23524585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
    Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
    Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors.
    Ikushima H; Todo T; Ino Y; Takahashi M; Miyazawa K; Miyazono K
    Cell Stem Cell; 2009 Nov; 5(5):504-14. PubMed ID: 19896441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CPEB1 modulates differentiation of glioma stem cells via downregulation of HES1 and SIRT1 expression.
    Yin J; Park G; Lee JE; Park JY; Kim TH; Kim YJ; Lee SH; Yoo H; Kim JH; Park JB
    Oncotarget; 2014 Aug; 5(16):6756-69. PubMed ID: 25216517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMGA2 sustains self-renewal and invasiveness of glioma-initiating cells.
    Zhong X; Liu X; Li Y; Cheng M; Wang W; Tian K; Mu L; Zeng T; Liu Y; Jiang X; Yu L; Gao L; Zhou Y
    Oncotarget; 2016 Jul; 7(28):44365-44380. PubMed ID: 27259253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective calcium sensitivity in immature glioma cancer stem cells.
    Wee S; Niklasson M; Marinescu VD; Segerman A; Schmidt L; Hermansson A; Dirks P; Forsberg-Nilsson K; Westermark B; Uhrbom L; Linnarsson S; Nelander S; Andäng M
    PLoS One; 2014; 9(12):e115698. PubMed ID: 25531110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of autophagic cell death of glioma-initiating cells by cell-penetrating D-isomer peptides consisting of Pas and the p53 C-terminus.
    Ueda Y; Wei FY; Hide T; Michiue H; Takayama K; Kaitsuka T; Nakamura H; Makino K; Kuratsu J; Futaki S; Tomizawa K
    Biomaterials; 2012 Dec; 33(35):9061-9. PubMed ID: 23006589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.